Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Terns discloses new THRB agonists for NASH

March 10, 2020

Indian approval of saroglitazar for noncirrhotic NASH

March 6, 2020

Givlaari receives European approval for Givlaari treatment of AHP in adults and adolescents

March 4, 2020

FDA approves Pizensy for oral solution for chronic idiopathic constipation in adults

March 4, 2020

Dosing begins in phase I study of KAN-101 for the treatment of celiac disease

Feb. 28, 2020

FDA approves Barhemsys for prevention and treatment of PONV

Feb. 27, 2020

Gilead Sciences patents IRAK-4 inhibitors

Feb. 27, 2020

Defibrotide safe in young patients with sickle cell disease undergoing stem cell transplantation

Feb. 26, 2020

Pandion begins first-in-human trial of PT-101 for autoimmune disease

Feb. 26, 2020

Guangzhou Henovcom Bioscience identifies new NR1H4 agonists

Feb. 25, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...